Literature DB >> 36247309

Knowledge base and emerging trends in YAP1 research.

Rong Xu1,2, Zhiying Yang1,2,3, Jiahui Fan1,2, Xueying Huang1,2, Linna Long1,2, Siying Yu1,2, Xiaorui Zhang1,2, Xia Li1,2,4, He Huang1,2,4.   

Abstract

Yes-associated protein 1 (YAP1) is a transcriptional coactivator that mediates the Hippo signaling pathway, which participates in the development and growth of the body; it plays key roles in tumorigenesis, metastasis, and therapy resistance. However, the pathophysiological mechanism of YAP1 has not been fully elucidated. Therefore, we explored the status and evolutionary trend in YAP1 research via bibliometric analysis. A total of 2,928 publications were downloaded from Web of Science Core Collection (WOSCC). The co-citation network map was drawn via CiteSpace and VOSviewer software. We analyzed the co-authorship networks among countries, journals, and authors, as well as co-occurrence of co-cited references, citation bursts, and keywords in YAP1 research, in order to predict its literature development. The present research evaluates the annual publication trends of YAP1 literature, and the following results were established: research on YAP1 are of steady increase; China present the highest co-citation; the Journal of Biological Chemistry (J Biol Chem) was the most productive journal, while Cell press received the most citations from co-cited references; Among the authors in the overall citations Bin Zhao is the most promising collaborator for emerging scholars in this field; and lastly, co-occurrence keyword analysis indicated that the emerging trends in YAP1 research were mainly focused on cancer therapy. We established that projects on YAP1 research is presently in its rapid developmental stage with active global collaboration. In addition, the mechanism and clinical significance of YAP1 in cancer was established as the potential trend of future studies. AJTR
Copyright © 2022.

Entities:  

Keywords:  CiteSpace; VOSviewer; YAP1; bibliometric analysis; citation burstiness; hippo signaling pathway

Year:  2022        PMID: 36247309      PMCID: PMC9556511     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   3.940


  36 in total

Review 1.  The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal.

Authors:  Bin Zhao; Karen Tumaneng; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2011-08-01       Impact factor: 28.824

2.  BET bromodomain is a novel regulator of TAZ and its activity.

Authors:  Qiong Duan; Yi Xiao; Lingyan Zhu; Zhenzhen Liu; Xiaoxiao Mao; Zhengxiang Zhou; Chaonan Liao; Jinxing Cai; Fulian Huang; Zehao Liu; Jian Zeng; Ke Xia; Cheng Chang; Jun Qi; Zihua Chen; He Huang; Tianlun Yang
Journal:  Biochim Biophys Acta       Date:  2016-10-04

Review 3.  Scientometric analysis of vital pulp therapy studies.

Authors:  K Kodonas; A Fardi; C Gogos; N Economides
Journal:  Int Endod J       Date:  2020-10-27       Impact factor: 5.264

4.  YAP1 increases organ size and expands undifferentiated progenitor cells.

Authors:  Fernando D Camargo; Sumita Gokhale; Jonathan B Johnnidis; Dongdong Fu; George W Bell; Rudolf Jaenisch; Thijn R Brummelkamp
Journal:  Curr Biol       Date:  2007-11-01       Impact factor: 10.834

5.  YAP1 is a potential biomarker for cetuximab resistance in head and neck cancer.

Authors:  Fredrik Jerhammar; Ann-Charlotte Johansson; Rebecca Ceder; Jenny Welander; Agneta Jansson; Roland C Grafström; Peter Söderkvist; Karin Roberg
Journal:  Oral Oncol       Date:  2014-06-30       Impact factor: 5.337

Review 6.  YAP/TAZ at the Roots of Cancer.

Authors:  Francesca Zanconato; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Cancer Cell       Date:  2016-06-13       Impact factor: 31.743

Review 7.  YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance.

Authors:  Frank Szulzewsky; Eric C Holland; Valeri Vasioukhin
Journal:  Dev Biol       Date:  2021-01-08       Impact factor: 3.148

8.  Knowledge Mapping of Drug-Induced Liver Injury: A Scientometric Investigation (2010-2019).

Authors:  Lixin Ke; Cuncun Lu; Rui Shen; Tingting Lu; Bin Ma; Yunpeng Hua
Journal:  Front Pharmacol       Date:  2020-06-05       Impact factor: 5.810

9.  YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma.

Authors:  Hirofumi Omori; Miki Nishio; Muneyuki Masuda; Yosuke Miyachi; Fumihito Ueda; Takafumi Nakano; Kuniaki Sato; Koshi Mimori; Kenichi Taguchi; Hiroki Hikasa; Hiroshi Nishina; Hironori Tashiro; Tohru Kiyono; Tak Wah Mak; Kazuwa Nakao; Takashi Nakagawa; Tomohiko Maehama; Akira Suzuki
Journal:  Sci Adv       Date:  2020-03-18       Impact factor: 14.136

10.  Targeting YAP1/LINC00152/FSCN1 Signaling Axis Prevents the Progression of Colorectal Cancer.

Authors:  Chunlin Ou; Zhenqiang Sun; Xiaoyun He; Xiaoling Li; Songqing Fan; Xiang Zheng; Qiu Peng; Guiyuan Li; Xiayu Li; Jian Ma
Journal:  Adv Sci (Weinh)       Date:  2019-12-05       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.